"Point Designs specializes in producing heavy-duty partial hand prostheses. Years of development and discussion with prosthetists and patients led us to design our flagship product, the Point Digit, a prosthetic finger for people with full finger loss. An ideal solution for patients with near-MCP level amputations/differences, the Point Digit moves like an anatomical finger, is robust, and can be positioned without another hand (unilaterally). With it, we answer the need for a full finger prosthesis that can be intuitively positioned and used in heavy-duty environments. At a lower cost than a powered bionic prosthesis, and with more function than a cosmetic restoration, the Point Digit helps many find independence in their daily lives."

During the past decade, Point Designs conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Point Designs" #1 collaborator was "University of Colorado, Denver" with 4 trials as a collaborator and "Arm Dynamics" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Point Designs" are "Amputation; Traumatic, Hand" (4 trials). Many other conditions were trialed in "Point Designs" in a lesser frequency.

Most popular intervention types in "Point Designs" are "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Point Digit" (2 trials) and "Point Partial" (2 trials). Other intervention names were less common.

The vast majority of trials in "Point Designs" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Point Designs". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Point Designs, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Point Designs, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".